153 related articles for article (PubMed ID: 33263421)
1. Management of High-Risk Breast Lesions: Counterpoint-Time for Personalized Surveillance.
Raza S
AJR Am J Roentgenol; 2021 Jun; 216(6):1434-1435. PubMed ID: 33263421
[No Abstract] [Full Text] [Related]
2. Management of High-Risk Breast Lesions: Point-Surveillance Is a Change in Practice Preceding Evidence-Based Standardization.
Calhoun BC
AJR Am J Roentgenol; 2021 Jun; 216(6):1432-1433. PubMed ID: 33263420
[No Abstract] [Full Text] [Related]
3. B3-lesions of the breast: Risk of malignancy after vacuum-assisted breast biopsy versus core needle biopsy diagnosis.
Pozzi G; Castellano I; D'Anna MR; De Matteis A; Milanesio L; Durando M; Ferrando PM; Bergamasco L; Ala A
Breast J; 2019 Nov; 25(6):1308-1309. PubMed ID: 31338958
[No Abstract] [Full Text] [Related]
4. Management of papillary lesions without atypia of the breast diagnosed on needle biopsy.
Yu Y; Salisbury E; Gordon-Thomson D; Yang JL; Crowe PJ
ANZ J Surg; 2019 May; 89(5):524-528. PubMed ID: 30414221
[TBL] [Abstract][Full Text] [Related]
5. Development of a Management Algorithm for the Diagnosis of Cellular Fibroepithelial Lesions From Core Needle Biopsies.
Jung J; Kang E; Chae SM; Kim H; Park SY; Yun B; Kim SM; Jang M; Kim SW; Kim EK
Int J Surg Pathol; 2018 Dec; 26(8):684-692. PubMed ID: 29774785
[TBL] [Abstract][Full Text] [Related]
6. Pathologic High-risk Lesions, Diagnosis and Management.
Murray M
Clin Obstet Gynecol; 2016 Dec; 59(4):727-732. PubMed ID: 27681693
[TBL] [Abstract][Full Text] [Related]
7. Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Rageth CJ; O'Flynn EAM; Pinker K; Kubik-Huch RA; Mundinger A; Decker T; Tausch C; Dammann F; Baltzer PA; Fallenberg EM; Foschini MP; Dellas S; Knauer M; Malhaire C; Sonnenschein M; Boos A; Morris E; Varga Z
Breast Cancer Res Treat; 2019 Apr; 174(2):279-296. PubMed ID: 30506111
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
[TBL] [Abstract][Full Text] [Related]
9. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Rageth CJ; O'Flynn EA; Comstock C; Kurtz C; Kubik R; Madjar H; Lepori D; Kampmann G; Mundinger A; Baege A; Decker T; Hosch S; Tausch C; Delaloye JF; Morris E; Varga Z
Breast Cancer Res Treat; 2016 Sep; 159(2):203-13. PubMed ID: 27522516
[TBL] [Abstract][Full Text] [Related]
10. Approach to Managing a Postmenopausal Patient.
Santen RJ; Heitjan DF; Gompel A; Lumsden MA; Pinkerton JV; Davis SR; Stuenkel CA
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32882039
[TBL] [Abstract][Full Text] [Related]
11. [New challenges of personalized therapy for breast cancer to pathologists].
Zhong X; Luo T; Zheng H; Bu H
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):219-21. PubMed ID: 24915809
[No Abstract] [Full Text] [Related]
12. Intraductal papilloma of the breast - management.
Hodorowicz-Zaniewska D; Szpor J; Basta P
Ginekol Pol; 2019; 90(2):100-103. PubMed ID: 30860277
[TBL] [Abstract][Full Text] [Related]
13. Management of high-risk breast lesions found on mammogram or ultrasound: the value of contrast-enhanced MRI to exclude malignancy.
Hammersley JA; Partridge SC; Blitzer GC; Deitch S; Rahbar H
Clin Imaging; 2018; 49():174-180. PubMed ID: 29571172
[TBL] [Abstract][Full Text] [Related]
14. Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines.
Lewin AA; Mercado CL
AJR Am J Roentgenol; 2020 Feb; 214(2):265-275. PubMed ID: 31825261
[No Abstract] [Full Text] [Related]
15. The use of a second core needle biopsy to predict response to neoadjuvant chemotherapy in breast cancer patients, especially in the HER2-positive population.
Zhang Y; Shen J; Wu S; Zhou Y; Shao Z; Liu G
Surgery; 2020 Dec; 168(6):1115-1121. PubMed ID: 32917430
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study.
Genco IS; Tugertimur B; Chang Q; Cassell L; Hajiyeva S
Virchows Arch; 2020 Feb; 476(2):209-217. PubMed ID: 31776645
[TBL] [Abstract][Full Text] [Related]
17. Preface for special issue "Advances in treatment and care in metastatic breast cancer".
Yamamoto Y; Tamura K
Chin Clin Oncol; 2018 Jun; 7(3):22. PubMed ID: 30056725
[No Abstract] [Full Text] [Related]
18. IAC Standardized Reporting of Breast Fine-Needle Aspiration Biopsy Cytology.
Field AS; Schmitt F; Vielh P
Acta Cytol; 2017; 61(1):3-6. PubMed ID: 27806362
[TBL] [Abstract][Full Text] [Related]
19. Management of High-Risk Breast Lesions.
Bahl M
Radiol Clin North Am; 2021 Jan; 59(1):29-40. PubMed ID: 33222998
[TBL] [Abstract][Full Text] [Related]
20. High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis.
Forester ND; Lowes S; Mitchell E; Twiddy M
Eur J Surg Oncol; 2019 Apr; 45(4):519-527. PubMed ID: 30579653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
